VANCOUVER, Feb. 23, 2017 /CNW/ – Northern Vertex Mining Corp (TSXV:NEE) is pleased to provide an update on its Mine Optimization Plan at the company’s 100% owned Moss Mine gold-silver project (“Moss Mine”), located in the historic Oatman Mining district in North West Arizona.
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter and full year 2016.
Fourth Quarter 2016 Highlights:
140% increase in clinical genetic testing volume(1)
122% increase in consolidated revenue to $60.5 million
11% reduction in average cost per clinical genetic
Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, today announced that U.S. Patent No. 9572807 was issued by the United States Patent and Trademark Office (USPTO) for NSI-189, the lead compound in Neuralstem’s neurogenic small molecule
Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, and Knight Therapeutics Inc. (TSX:GUD) (Knight), a leading Canadian specialty pharmaceutical company, today announced that Knight’s New Drug Submission (NDS) for ILUVIEN® has been accepted for review by Health Canada. ILUVIEN (fluocinolone acetonide intravitreal
FIRST MAJESTIC SILVER CORP. (FRANKFURT:FMV)(TSX:FR)(NYSE:AG)(BVM:AG) (the “Company” or “First Majestic”) is pleased to announce the consolidated financial results for the Company’s fourth quarter and year ended December 31, 2016. The full version of the financial statements and the management discussion and analysis can be viewed on the Company’s website at
Vancouver, B.C., February 21, 2017: Exeter Resource Corporation (NYSE-MKT:XRA, TSX:XRC, Frankfurt: EXB – “Exeter” or the “Company”) is pleased to announce that it has commenced a 6,000 metre drill program on its 100% owned Caspiche gold-copper project in Chile.
Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a developer of innovative materials as hemostatic and wound care devices, today announced the pricing of a registered direct offering of 10,166,664 units, each unit consisting of a share of the Company’s common stock, and 0.55 of a Series F Warrant (“Series F
Imaging3, Inc. (OTCQB:IGNG) announced today that, after several months of verification and validation, CriTech Research Inc. has completed its remediation review and testing of Imaging3 DominionVI SmartScan™ software, thus allowing the company to move forward towards filing its FDA 510(k) application.
For over 23 years, CriTech has developed and tested safety-critical
Marrone Bio Innovations, Inc. (MBI), (NASDAQ:MBII), a leading manufacturer and marketer of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets, hosted a training featuring eight Florida and Georgia experts reviewing the most current data on nematode management. Enrolled in this CEU
NewLink Genetics Corporation (NASDAQ:NLNK), today reported that it will release its fourth quarter and year end 2016 financial results on Tuesday, February 28, 2017. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results and to give an update on clinical and
Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), announced that it presented a poster of its immunological data from its 94-patient Phase 2 trial evaluating vesigenurtacel-L (HS-410) either alone or in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC) at the 2017 Genitourinary (GU) Cancers Symposium. Researchers reported that HS-410,
Immune Pharmaceuticals Inc. (Nasdaq: IMNP), will announce on Monday, February 20th, 2017 at the Acute Leukemia XVI symposium in Munich, Germany that it will be launching REMAIN™, an international Overall Survival clinical study with the combination of Ceplene®, the Company’s flagship product for Acute Myeloid Leukemia (AML) remission maintenance and
Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today announced the enrollment of the first patient in a Phase 3 clinical trial (“SAPPHIRE”) of Zuprata™, its proprietary suspension formulation of the corticosteroid triamcinolone acetonide, used together with EYLEA® (aflibercept) for the treatment
Valeritas Holdings (OTCQB:VLRX) today announced data showing greater reductions in A1c and insulin dose in patients with type 2 diabetes who used V-Go® Wearable Insulin Delivery device compared to patients using insulin pen devices. The data were presented as an E-Poster at The 10th International Conference on Advanced Technologies &
The U.S. Army Communications and Electronics Command (CECOM) Software Engineering Center (SEC) has awarded ManTech International Corporation (Nasdaq:MANT) a Software and Systems Engineering Services Next Generation prime contract to provide worldwide systems field and software support for the Army’s intelligence and C3/LOG-IT systems. The cost-plus-fixed-fee task order has a 12-month
Blucora, Inc. (NASDAQ:BCOR), a leading provider of technology-enabled financial solutions to consumers, small businesses and tax professionals, today announced financial results for the fourth quarter and full year ended December 31, 2016.
“Our business results exceeded our expectations in the fourth quarter,” said John Clendening, President and Chief Executive Officer of Blucora.
By Jocelyn Aspa
Uranium Resources (NASDAQ:URRE) has announced that it has completed a registered direct offering with Aspire Capital Fund, where Aspire purchased a combination of 2,748,101 common shares and pre-funded common stock warrants at $1.58.
As quoted in the press release:
Gross proceeds from the offering were $4.5 million. The common shares and pre-funded
IXYS Corporation (NASDAQ:IXYS) an international power and IC semiconductor company, today announced that its wholly owned UK subsidiary, IXYS UK Westcode Ltd., launched a new higher voltage class fast distributed gate thyristor. This new fast thyristor with turn-off time of as little as 65 microseconds and current rating of 1055
Stillwater Mining Company (“Stillwater” or “the Company”) (NYSE:SWC) today reported financial results for the quarter and year ended December 31, 2016.
Fourth Quarter 2016 Highlights:
Announced proposed acquisition of Stillwater by Sibanye Gold Limited (“Sibanye”) for USD$18 per share in cash
PGM mined sales of 134,500 ounces, an increase of 11.8%